← European Medicine Shortage Tracker · all medicines

Attenuated shortage — availability across Europe

Attenuated currently has availability issues reported in 1 European register: Greece.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Limited availability  ATC J07BD54 · also listed as: ATTENUATED · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Attenuated, covering 1 affected product presentation. The longest-running open report was filed in Greece on 2024-11-30 and has now been open for about 21 months. The furthest expected-resolution date currently on file is 2027-12-31; the earliest is 2027-12-31. Registers in Greece indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Attenuated is coded J07BD54 — a medicine acting on anti-infectives for systemic use — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇬🇷 GreeceLimited availability
ΜΕ ΔYΟ ΧΩΡΙΣΤEΣ ΒΕΛOΝΕΣ) X 0,5 ML SOLVENT
2024-11-302027-12-31ΕΜΒΟΛΙΟ Α.Ε.Β.Ε. ουσία
Alternatives: Εναλλακτικά άλλο εμβόλιο σύμφωνα με τις συστάσεις του θεράποντος ιατρού VARILRIX (ΕΜΒ. ΑΝΕ
register ↗

Full report history (1 register entry)

Every individual register entry for Attenuated in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇬🇷 GRΜΕ ΔYΟ ΧΩΡΙΣΤEΣ ΒΕΛOΝΕΣ) X 0,5 ML SOLVENTLimited availability2024-11-302027-12-31ΕΜΒΟΛΙΟ Α.Ε.Β.Ε. ουσία

Frequently asked

Is Attenuated currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Greece. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Attenuated shortage expected to end?

Agency prognoses on file range from 2027-12-31 to 2027-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Attenuated?

1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Attenuated availability data come from?

Directly from the official medicines-agency register that lists Attenuated: EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Attenuated — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/attenuated/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Attenuated availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/attenuated/">Attenuated shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Attenuated: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.